相关临床试验
药物批准
监管机构
成立时间
2018
The company's mission is to become a global leader in the discovery, development and commercialization of innovative molecular-targeted immuno-oncology drugs to treat cancer. The company focuses on R&D, production and commercialization of innovative drugs. The main products are anti-tumor drugs, etc.
别名:
暂无试验阶段数据